Apella Capital’s Alpha Tau Medical DRTS Stock Holding History

Apella Capital’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.45M	Hold	382,284	–	–	0.07%	175
2026 Q2	$4.88M	Hold	382,284	–	–	0.07%	165
2026 Q1	$3.07M	Hold	382,284	–	–	0.05%	214
2025 Q4	$1.89M	Buy	+382,284	New	+$1.61M	0.04%	204

Other funds holding DRTS

DSC

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $479M AUM 15.43% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Apella Capital's DRTS Position: Q3 2026 in Review

Apella Capital held its Alpha Tau Medical (DRTS) position steady in Q3 2026 at 382,284 shares worth $5.45M. The position accounts for 0.07% of the portfolio, ranked #175.

Apella Capital first reported a position in DRTS in Q4 2025 and has held it in 4 quarters since. 10 funds tracked by Wall St. Rank hold DRTS as of Q3 2026.

Apella Capital held 382,284 shares of Alpha Tau Medical worth $5.45M as of Q3 2026.
Apella Capital left its Alpha Tau Medical share count unchanged in Q3 2026.
Alpha Tau Medical made up 0.07% of Apella Capital's portfolio in Q3 2026, its #175 holding.
Apella Capital first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 4 quarters since.
10 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.